Q3 2024 Holdings
Filed 2024-11-12 | 62 holdings | $241.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares TR(QUAL) | MSCI USA QLT FCT | 46432F339 | $60.5M | 337,472 | 25.1% |
| Invesco QQQ TR(QQQ) | UNIT SER 1 | 46090E103 | $43.0M | 88,149 | 17.8% |
| Ishares TR(IQLT) | MSCI INTL QUALTY | 46434V456 | $42.6M | 1,026,290 | 17.7% |
| Ishares TR(EFV) | EAFE VALUE ETF | 464288877 | $23.0M | 399,186 | 9.5% |
| Vanguard Index FDS(VTV) | VALUE ETF | 922908744 | $16.9M | 96,630 | 7.0% |
| Select Sector Spdr TR(XLP) | SBI CONS STPLS | 81369Y308 | $13.7M | 165,267 | 5.7% |
| Ishares TR(EWU) | MSCI UK ETF NEW | 46435G334 | $7.8M | 209,344 | 3.2% |
| Ishares Inc(EWJ) | MSCI JPN ETF NEW | 46434G822 | $7.8M | 108,634 | 3.2% |
| Astrazeneca PLC(AZN)Call | SPONSORED ADR | 046353108 | $5.0M | 64,000 | 2.1% |
| Select Sector Spdr TR(XLU) | SBI INT-UTILS | 81369Y886 | $4.2M | 51,940 | 1.7% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $999.2K | 8,969 | 0.4% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $920.2K | 17,785 | 0.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $684.6K | 4,585 | 0.3% |
| Amgen Inc(AMGN)Call | COM | 031162100 | $644.4K | 2,000 | 0.3% |
| Amgen Inc(AMGN)Put | COM | 031162100 | $644.4K | 2,000 | 0.3% |
| Soleno Therapeutics Inc(SLNO)Call | COM | 834203309 | $631.1K | 12,500 | 0.3% |
| Crispr Therapeutics AG(CRSP)Call | NAMEN AKT | H17182108 | $615.4K | 13,100 | 0.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $574.1K | 7,865 | 0.2% |
| Indivior PLC(INDV) | ORD | G4766E116 | $564.2K | 57,293 | 0.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $560.8K | 633 | 0.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $516.6K | 953 | 0.2% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $490.1K | 9,706 | 0.2% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $481.8K | 6,600 | 0.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $466.0K | 8,025 | 0.2% |
| Novo-Nordisk A S(NVO)Call | ADR | 670100205 | $464.4K | 3,900 | 0.2% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $421.0K | 4,115 | 0.2% |
| Cassava Sciences Inc(SAVA)Put | COM | 14817C107 | $415.0K | 14,100 | 0.2% |
| Ultragenyx Pharmaceutical in(RARE)Call | COM | 90400D108 | $383.3K | 6,900 | 0.2% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $377.8K | 13,100 | 0.2% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $356.9K | 7,857 | 0.1% |
| Avadel Pharmaceuticals PLCCall | COM SHS | G29687103 | $343.6K | 26,200 | 0.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $341.6K | 6,684 | 0.1% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $310.1K | 13,188 | 0.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $307.8K | 5,240 | 0.1% |
| Viridian Therapeutics Inc(VRDN)Call | COM | 92790C104 | $298.0K | 13,100 | 0.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $282.0K | 2,468 | 0.1% |
| Moderna Inc(MRNA)Call | COM | 60770K107 | $274.0K | 4,100 | 0.1% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $267.6K | 13,020 | 0.1% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $252.0K | 33,650 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $242.2K | 2,618 | 0.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $235.6K | 4,241 | 0.1% |
| Celldex Therapeutics Inc New(CLDX)Put | COM NEW | 15117B202 | $220.9K | 6,500 | 0.1% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $206.6K | 19,939 | 0.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $185.5K | 26,200 | 0.1% |
| Applied Therapeutics Inc(APLT)Call | COM | 03828A101 | $172.6K | 20,300 | 0.1% |
| Altimmune Inc(ALT)Call | COM NEW | 02155H200 | $160.9K | 26,200 | 0.1% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $149.9K | 21,596 | 0.1% |
| Altimmune Inc(ALT)Put | COM NEW | 02155H200 | $144.3K | 23,500 | 0.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $128.1K | 46,923 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA)Call | COM | 462260100 | $123.0K | 13,100 | 0.1% |